INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

76,375 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
HS
Hooda SheilaDirector
ACTEnact Holdings, Inc.
Grant or award
A—
201 sh
Jun 18, 2026Jun 23, 2026
Page 784 of 1910
← PrevNext →
traded Jun 18, 2026
+5d
SEC Form 4

Evidence

15
WM
Williams John MoganSenior Vice President
BHBBAR HARBOR BANKSHARES
Grant or award
A$2,832
78 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
GB
Gould BrianEVP & Chief Operations Officer
ACTEnact Holdings, Inc.
Grant or award
A—
12 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
DM
Derstine MichaelEVP and Chief Risk Officer
ACTEnact Holdings, Inc.
Grant or award
A—
39 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
5 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
SE
Stolove EvanEVP, Gen. Counsel & Secretary
ACTEnact Holdings, Inc.
Grant or award
A—
15 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
FD
Fisk John DDirector
ACTEnact Holdings, Inc.
Grant or award
A—
201 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
RP
Raman PrakashDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
ME
Mitchell H ElizabethDirector
ACTEnact Holdings, Inc.
Grant or award
A—
56 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
10 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
HG
Hrustanovic GorjanDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
MD
Mitchell Hardin DeanEVP, CFO and Treasurer
ACTEnact Holdings, Inc.
Grant or award
A—
58 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

15
GR
Gupta RohitDirector, President and CEO
ACTEnact Holdings, Inc.
Grant or award
A—
173 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
400 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
300 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
IO
Iglesias Sanchez OscarDirector
CDROCodere Online Luxembourg, S.A.
Open-market sale · 10b5-1 plan
SELL$143K
14.3K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
100 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
200 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

14
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
200 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

13
MA
Miller AineSVP, DEV & HEAD OF IRE OFFICE
TBPHTheravance Biopharma, Inc.
Grant or award
A—
18.8K sh
Jun 19, 2026Jun 23, 2026
traded Jun 19, 2026
+4dSEC Form 4

Evidence

13
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Option exercise
M—
9,237 sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$2,270
422 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

13
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$52K
145 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

13
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$51K
145 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

13
KE
Kargieman EmilianoDirector, Chief Executive Officer, 10% Owner
SATLSatellogic Inc.
Option exercise
M—
26.5K sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

13
SH
Schwartz Sanford HaroldDirector
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
17.4K sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

13
GN
Gomez Aidan N.Director
RIVNRivian Automotive, Inc. / DE
Grant or award
A—
17.4K sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

12
GD
Graff Marc D.SVP & Chief Financial Officer
CIENCIENA CORP
Tax withholding
F$85K
199 sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

12
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$29K
9,722 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

12
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
9,700 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

12
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
8,432 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

12
AT
Agnes TangDirector
IPGPIPG PHOTONICS CORP
Open-market sale · 10b5-1 plan
SELL$63K
536 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

12
AT
Agnes TangDirector
IPGPIPG PHOTONICS CORP
Open-market sale · 10b5-1 plan
SELL$91K
775 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC Form 4

Evidence

12
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$30K
9,722 sh
Jun 23, 2026Jun 23, 2026
traded Jun 23, 2026
+0dSEC Form 4

Evidence

12
CM
Chu MonaChief Accounting Officer
PEverpure, Inc.
Tax withholding
F$214K
2,864 sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

11
RP
Restrepo Robert P JrDirector
ACTEnact Holdings, Inc.
Grant or award
A—
201 sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

11
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

11
NP
Naude PierreDirector
NCNOnCino, Inc.
Grant or award
A—
12.9K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC Form 4

Evidence

11
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Tax withholding
F$312K
728 sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence

11
BJ
Brau Donnelly JuliaChief Financial Officer
PINSPINTEREST, INC.
Tax withholding
F$729K
35.9K sh
Jun 20, 2026Jun 23, 2026
traded Jun 20, 2026
+3dSEC Form 4

Evidence